This demonstrates for the first time to our knowledge that gliomas with IDH2 R172 mutations can have elevated 2HG, that any cancer with IDH1 R132L or IDH2 R172M have elevated 2HG, and that 2HG in cancer tissues is specific for (R)-2-hydroxyglutarate. The gene discussed is IDH2; the disease is cancer.